Press releases
Stay current with the latest press releases from within the industry.
Submit Press Release
Latest Press Releases
Pharmalicensing and Bionow sign strategic marketing and member benefit agreement
York, UK & Manchester, UK -- May 20th, 2013 – Pharmalicensing, a division of IP Technology Exchange, Inc, today announced it has agreed a partnership with Bionow, the membership company... more
Beacon Launch New Website
Beacon announces the launch of a new improved website to enhance communications with our stakeholders. more
Beacon Launch Streptokinase
Beacon Pharmaceuticals Ltd is pleased to announce the launch in the UK of Stretokinase. more
A New Therapeutic Approach to Treat Oral Mucositis Using Specific MMP Blockers in an Osmotically Active Solution.
Abstract
Mucositis is a consequence of cytostatic effects of anticancer therapy on the fast growing oral mucosal cells. The size of the ulcer increases due to subsequent bacterial and fungal... more
Press release search
Most viewed press releases
euroPLX Introduces Tool to Overcome Reject vs. Accept Dilemma in Partnering
Genesis Conference on target to exceed all previous years
TDS® TESTOSTERONE EXCEEDS ANDROGEL® OUTCOMES
Labtec´s sufentanil patch for chronic pain enters phase II in cooperation with hameln rds GmbH
More recent press releases
General Information
VITRO-BIO Pharma France
ZAC de Lavaur
63500 ISSOIRE
France
www.vitrobio.com
Founded 1994
Private ownership
(more)
Comparison of a Hypertonic Tannin-rich Solution vs 3% NaCl Solution as Treatment for Rhinosinusitis
ABSTRACT
Rhinosinusitis (RS), chiefly viral in origin, is increasingly widespread, and puts heavy financial burdens on society. Treatments range from home remedies and alpha-adrenergic agonistic decongestants to antibiotics, corticosteroids, and even
(more)
Innopharmax announces its participation in BIO International Convention 2013 in Chicago(4/22-25). Booth number: 4878 (more)
One of the Most International and Economic Partnering Conferences
EUR 35 and 55 per pre-arranged face-to-face meeting makes euroPLX unmatched in terms of economy. (more)
ABSTRACT
Presence of free Herpes Simplex Virus (HSV) particles in the vaginal cavity and consequent continuous infection of new healthy cells delay the recovery from Genital herpes (GHSV). As the HSV envelop contains several surface proteins an
(more)
euroPLX Meetings to Continue Strongly in 2013
euroPLX announces confirmed events in 2013, all open for registration. (more)
Jubilee euroPLX Meeting Attracted Opportunities From 36 Countries
The 50th "jubilee" euroPLX Meeting in Sorrento marks an important milestone; world's most often held pharma partnering event. (more)
Rivastigmine Patch for LATAM Markets
Amarin Technologies S.A. has licensed its Rivastigmine Patch to Asofarma S.A. , for Brazil and Argentina markets. (more)
euroPLX 50 Sorrento - More Global Opportunities Than Ever
euroPLX partnering conferences more international than other pharma or biotech partnering events and are becoming ever more global as the 50th euroPLX Meeting shows. (more)
Labtec joins the CPHI/ICSE in Madrid, October 9-11th, 2012
The International Contract Service Event (“ICSE”), taking place in Madrid from 9th until 11th October 2012, is co-located with the “CPhI Worldwide” – the biggest international fair for the pharmaceutical industry. (more)
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us